Methodology of analgesic-muscle relaxant evaluation. Experience with orphenadrine citrate compound.
D000328:Adult; D001241:Aspirin / Q000494:pharmacology; D002110:Caffeine / Q000494:pharmacology; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D009132:Muscles / Q000627:therapeutic use*; D009966:Orphenadrine / Q000494:pharmacology / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy*; D010615:Phenacetin / Q000494:pharmacology
D002110:Caffeine; D009966:Orphenadrine; D010615:Phenacetin; D001241:Aspirin